AIM IMMUNOTECH INC: ADDITIONAL MEDIAN OVERALL SURVIVAL AND IMMUNE-RESPONSE DATA ON AMPLIGEN EXPECTED MID-YEAR 2027

Reuters · 1d ago

Please log in to view news